Repros Therapeutics Inc. Reports Third Quarter 2010 Financial Results and Provides Corporate Update

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc.® (NasdaqCM: RPRXD) today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.

MORE ON THIS TOPIC